Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Enabling Total Biopharma Solutions
Pall Life Sciences
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Changing Column Packing from an Art into a Science
Overcoming Obstacles in AAV Viral Vector Manufacturing
View All Featured ArticlesHeadline News
Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer
Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study
Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Changing the Paradigm: Moving to In-Process Release Testing
Presented by Presented by Scott Weiss, Director, Industrial Microbiology at Johnson & Johnson and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
05th February 2021
Case Study: An End-to-End Solution for Large Scale Adenovirus Manufacturing
Presented by Clive Glover, PhD, Senior Marketing Manager, Cell & Gene Therapy at Pall and Rachel Legmann, PhD, Senior Manager, Process Development Services at Pall
13th November 2018
Single Use Process for Production of AAV Gene Therapy Products
Presented by Lance Marquardt, Associate Director -Upstream Processing Gene Therapy, Hopewell Biologics Manufacturing at PTC Therapeutics, Vikas Gupta, Vice President and GM Downstream Bioprocessing and Gene Therapy, Rachel Legmann, Senior Director of Technology, Gene Therapy at Repligen and Gilbert Huang, Senior Field Application Scientist at Repligen
26th May 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Amsphere TM A3
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
